跳至主要内容
临床试验/CTRI/2023/03/050316
CTRI/2023/03/050316已完成Unknown

Pilot Study for Validation of metabolite signatures across stages and types of Cancer (Stage I to Stage IV) in Adult Male Population and Female Populations using Metabolite Bio-Signatures and subsequent utilization of data on an Artificial Intelligence (AI) platform to validate an early detection software. - PDMX-05

Dr Imliwati Longkumer0 个研究点目标入组 2,700 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
2,700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Cancer patients within the age group of 18 to 75 yrs
  • 2. Individuals who have been diagnosed for any of the Cancer types

排除标准

  • 1. Individuals with no known cancer, high-grade dysplasia, autoimmune disease, or
  • chronic kidney disease.
  • 2. Cancer patients who have received any kind of Immuno / chemo / radiation /
  • medical / etc. therapy

研究者

发起方
Dr Imliwati Longkumer

相似试验